Yale-New Haven achieves Stage 7
Yale-New Haven Hospital (YNNH) has attained Stage 7 status from HIMSS Analytics--recognition for use of a complete EMR in an advanced IT setting.
YNHH is the primary teaching hospital for the Yale School of Medicine with 1,541 beds serving patients on campuses including the Yale-New Haven Children's Hospital, Yale-New Haven Psychiatric Hospital and Smilow Cancer Hospital.
The EMR Adoption Model was developed by HIMSS Analytics in 2005 to evaluate the progress of hospitals using integrated EMR systems. Clinics, outpatient centers and physician practices are evaluated for their use of technology. To achieve Stage 7 status, a HIMSS Analytics executive and or chief information officer must make a site visit to confirm their status. Just 3.7 percent of U.S. hospitals in the HIMSS Analytics database have been awarded this distinction as of the second quarter of 2015.
"It was clear from my visit to Yale-New Haven Hospital that they are serious about their mission, vision and values," said John H. Daniels, global vice president of HIMSS Analytics' healthcare advisory services group, in a press statement. "They are leveraging their EHR technology in very innovative ways."
YNHH's achievementsinclude "saving time and improving the patient experience through radiology protocolling using the EHR," said Daniels. "Their eICU has proven its value, particularly when caring for patients in isolation; research recruitment is integrated in the patient portal; and they have proven the value of clinical decision support evidenced by their smoking cessation protocol compliance project."
Yale-New Haven Hospital will be recognized at the 2016 Annual HIMSS Conference & Exhibition, beginning Feb. 29, 2016, in Las Vegas.